Abstract:
NEW MATERIAL:A propane derivative of formula I (R is lower alkyl; one of A and B is formula II and the other is formula III, but A and B are different from each other; R1 and R2 are H, lower alkyl, aryl or arylalkyl, and R1 and R2 may be the same or different with or from each other; R3 is lower alkyl, aryl or heterocyclic ring residue which may have a substituent; n is 2 or 3; X is sulfonyl or cabonyl) or an acid-added salt thereof. EXAMPLE:1-(3,4-Dimethoxybenzene sulfonyl)-4-(3-isobutoxy-2- methylbenzylaminopropyl)piperazine. USE:Useful as a medical agent acting on circulatory systems. PREPARATION:For example, the compound of formula I is obtained by reacting a compound of formula IV with a compound of formula V preferably in a solvent in the presence of a base at 0-200 deg.C and subsequently reacting the product with a compound of formula VII at 0-100 deg.C as shown in the reaction formula.
Abstract:
PURPOSE:To industrially and advantageously obtain the titled compound useful as an intermediate for antiallergic agents, drugs for cardiovascular systems etc., by converting 8-methoxy-2H-1-benzopyran into a halohydrin, reacting the resultant product with a base and reducing the resultant epoxidized product. CONSTITUTION:8-Methoxy-2H-1-benzopyran expressed by formula II is converted into a halohydrin of trans-3-halogeno-4-hydroxy-8-methoxy-3,4-dihydro-2H- benzopyranexpressedby formula III, which is then reacted with a base and epoxidized to give 3,4-epoxy-3,4-dihydro-8-methoxy-2H-1-benzopyran expressed by formula IV. The resultant compound expressed by formula IV is further reduced to afford the aimed compound expressed by formula I.
Abstract:
NEW MATERIAL:The compound of formula I (R1 is phenyl or pyridyl which may be substituted with 1-2 halogen, nitro or CF3, or benzoxadiazolyl; R2 is lower alkyl; R3 is H, formyl, carboxyl, etc.; A is straight-chain or branched- chain lower alkylene; B is 1-6C straight-chain alkylene; X is direct bond or O). EXAMPLE:2, 6-Dimethyl-4-(3-nitrophenyl)-1, 4-dihydropyridine-3, 5-dicarboxylic acid 3-methyl ester 5-[4-(1-imidazolylmethyl)phenylmethyl] ester. USE:Vasodilator, hypotensor, antithrombotic agent and antiarteriosclerotic agent. PREPARATION:The compound of formula I can be produced by reacting the compound of formula II with N,N'-carbonyldiimidazole in an inert solvent and reacting the reaction product with the compound of formula III.
Abstract:
NEW MATERIAL:The compound of formula I [R is imidazolyl or pyridyl; R1 is H, halogen, nitro or CF3; R2 is lower alkyl; X is CH or N; Z is lower alkylene, group of formula II (B is lower alkylene or 0-lower alkylene), formula III (R4 is H or R2) or formula IV; m is 1-3; n is 1 or 2]. EXAMPLE:2,6-Dimethyl-4-( 3-nitrophenyl )-1,4-dihydropyridine-3,5-dicarboxylic acid 3-ethyl ester 5-{2-{4-[2-(1-imidazolyl)-ethoxy]-benzoyloxy}-ethyl}-ester. USE:A drug effective as a vasodilator, hypotensor, antithrombogenetic agent, antiarteriosclerotic agent, etc. PREPARATION:The compound of formula I can be prepared e.g. by reacting the compound of formula V or its N-protected compound with the compound of formula VI (Hal is halogen), and reacting the resultant compound with the compound of formula RH.
Abstract:
PURPOSE:To provide a new pyrano[2,3-f]quinoline derivative having excel lent antiarrhythmic action, cardiac action, vasodilative action, etc., and useful as a cardiac disease therapeutic agent represented by cardiac failures. CONSTITUTION:The compound of formula 1 (R is lower alkyl; R is H, halogen, OH, lower alkylsulfonyloxy, lower alkanoyloxy, lower alkoxy, azido, amino; R is H, lower alkyl; R is H, lower alkyl, OH, lower alkylamino, pyrrolidinyl or piperazinyl which may have a substituent; when a double bond exists between the 3,4 positions, the substituent R does not exist), e.g. 3acetoxy-6-methyl-3,4,7,8- tetrahydro-2H-pyrano[2,3-f]quinoline. The compound of formula 1-1 among the compounds of formula 1 is obtained by reacting a quinoline compound with an allyl halide compound, thermally subjecting the obtained compound of formula 3 to a Claisen rearrangement, reacting the reaction product with an aliphatic acid anhydride, reacting the obtained compound of formula 5 with a peracid, and subsequently treating the produced epoxy compound of formula 6 with an alkali halide.
Abstract:
NEW MATERIAL:A sulfonamide compound shown by the formula (R1 is lower alkyl, lower alkoxy or halogen; R2 is H, lower alkyl, aryl or arylalkyl; R3 is aryl or arylalkyl; R4 and R4' may be the same or different and H, lower alkyl or lower alkoxy; m is 0-3; n is 1-8) and an acid addition salt thereof. EXAMPLE:1-Diphenylmethyl-4-(3-benzenesulfonylaminopropyl)piperazine. USE:Useful as a drug for cardiovascular system. PREPARATION:For example, a compound shown by formula II is reacted with a compound shown by formula III in a solvent such as methylene chloride or chloroform at -10-+100 deg.C, preferably in the presence of a base such as sodium hydroxide to give a compound shown by formula I wherein R2 is H. Further this compound is reacted with a compound shown by the formula R2'Y (R2' is R2 except H; Y is halogen, alkylsulfonyloxy, etc.) and converted to a compound shown by formula I wherein R2 is except H.
Abstract:
NEW MATERIAL:The compound of formula I [R1 and R2 are H or lower alkoxy; A is single bond, lower alkylene or lower alkenylene; R3 and R4 are lower alkyl or R3 and R4 together form lower alkylene; R5 is -X-(CO)n-Y (X is single bond, lower alkylene, etc.; n is 0 or 1; Y is H, cycloalkyl, aryl, etc.), etc.]. EXAMPLE:4-[4-( Carbamoylmethyl )piperidinocarbonylmethyl]phenyl 4-guanidino benzoate dihydrochloride. USE:It has the activity of proteolytic enzyme and is useful for the remedy of pancreatitis, thrombotic syndrome, etc. PREPARATION:The compound of formula I can be produced by carrying out dehydrative condensation of p-nitrobenzoic acid of formula II with the compound of formula III, reducing the resultant compound of formula IV to convert the nitro group to amino group and guanidinating the product.
Abstract:
PURPOSE:To obtain a 3,8-dihydroxy compound by dividing 3,4-dihydro-8-- protected-hydroxy-3-optically active acyloxy-2H-1-benzopyrane into 3R isomer and 3S isomer and eliminating the acyl group and the OH-protecting group. CONSTITUTION:A compound of formula I (A* is acyl group derived from optically active amino acid; Z is H or protecting group) is divided into 3R isomer and 3S isomer by column chromatography and the acyl group and the OH- protecting group are eliminated from the isomers in an arbitrary order to obtain (3R)- or (3S)-3,8-dihydroxy compound. The compound of formula I can be produced by reacting a compound of formula I wherein OA is OH with a compound of formula II (e.g., L-alanine having protected amino group) or by reacting a compound of formula III with a compound of formula II and reacting the product successively with a peracid and an alkali halide, etc. The obtained 3,8-di-OH compound is useful as an intermediate for a drug for circulatory system.
Abstract:
PURPOSE:To obtain the titled substance useful as pharmaceuticals, etc., easily, without producing by-products, by reacting an o-allylphenol acetyl ester with an epoxidizing agent and cyclizing the obtained specific compound in the presence of an alkali halide, etc. CONSTITUTION:The compound of formula I (R is H, lower alkyl, lower alkoxy, halogen or nitro; n is 1-3; plural R groups may be same or different; R is lower acyl) is used as a raw material, and is made to react in the presence of an alkali halide or a quaternary ammonium halide, in a solvent (preferably acetone, etc.) at 50-120 deg.C under refluxing, and if necessary the product is deacylated to obtain the compound of formula II (R is H or acyl). The amount of the alkali halide or quaternary ammonium halide is preferably 0.1-1 mol- equivalent.
Abstract:
PURPOSE:To obtain a new indole derivative having positively inotropic action on cardiac muscle, antiarrhythmic action and vasodilating action and useful as an agent for the treatment of heart diseases such as cardiac insufficiency and arrhythmia. CONSTITUTION:This indole derivative is expressed by formula I (one of R to R is a lower alkyl or a lower alkenyl and the others each is H or a lower alkyl; R and R each is H, a halogen, etc.; R is H, benzyl, etc.; R and R each is H, OH, etc.; A is group of formula II, III, etc.) or its salt, e.g. 2-(1- imidazolylmethyl)-2,3, 7,8-tetrahydro-5,8,8-trimethyl-6H-furo[2,3-e]indol-7-one. The compound can be produced e.g. by reacting an indole compound of formula IV with an allyl halide of formula V (X is a halogen), heating the obtained compound of formula VI to effect the Claisen rearrangement reaction and reacting the product with a halogenating agent such as N-bromosuccinimide.